Detalhe da pesquisa
1.
Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study.
Ann Intern Med
; 176(4): 496-504, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37011399
2.
Prospective assessment of humoral and cellular immune responses to a 3rd COVID-19 mRNA vaccine dose among immunocompromised individuals.
J Infect Dis
; 2023 Nov 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37972260
3.
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS).
Clin Infect Dis
; 75(1): e630-e644, 2022 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35179197
4.
Measuring Mobility in Low Functioning Hospital Patients: An AM-PAC Replenishment Project.
Arch Phys Med Rehabil
; 101(7): 1144-1151, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32173327
5.
Including and Training Family Caregivers of Older Adults in Hospital Care: Facilitators and Barriers.
J Nurs Care Qual
; 35(1): 88-94, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-30889081
6.
Innovative approaches to interprofessional care at the University of Pittsburgh Medical Center.
J Interprof Care
; 29(5): 520-1, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26171868
7.
COVID-19 contagious health care personnel 5-day early return-to-work program.
Am J Infect Control
; 51(7): 746-750, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36410551
8.
Implementing a Discharge Follow-up Phone Call Program Reduces Readmission Rates in an Integrated Health System.
J Healthc Qual
; 45(6): 315-323, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37788411
9.
Assessment of the effectiveness of ultraviolet-C disinfection on transmission of hospital-acquired pathogens from prior room occupants.
Antimicrob Steward Healthc Epidemiol
; 2(1): e110, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36483381
10.
Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.
Open Forum Infect Dis
; 9(10): ofac517, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36324319
11.
A learning health system approach to the COVID-19 pandemic: System-wide changes in clinical practice and 30-day mortality among hospitalized patients.
Learn Health Syst
; 6(3): e10304, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35860323
12.
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days.
Contemp Clin Trials
; 113: 106652, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34896293
13.
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19.
JAMA Netw Open
; 5(4): e226920, 2022 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35412625
14.
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial.
JAMA Netw Open
; 5(7): e2220957, 2022 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35834252
15.
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial.
Contemp Clin Trials
; 119: 106822, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35697146
16.
Performing the Wrong Procedure.
JAMA
; 316(11): 1207-1208, 2016 Sep 20.
Artigo
Inglês
| MEDLINE | ID: mdl-27654607
17.
Preprocedural SARS-CoV-2 Testing to Sustain Medically Needed Health Care Delivery During the COVID-19 Pandemic: A Prospective Observational Study.
Open Forum Infect Dis
; 8(2): ofab022, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33604405
18.
Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment.
J Am Coll Emerg Physicians Open
; 2(5): e12550, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-34568870
19.
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Open Forum Infect Dis
; 8(7): ofab254, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34250192
20.
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.
Trials
; 22(1): 363, 2021 May 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34034784